Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Naimark

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Journal of the American Society of Nephrology : JASN|March 1, 2023
The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 CohortsMorgan E Grams, Nigel J Brunskill, Shoshana H Ballew, et al.
European Heart Journal|January 24, 2023
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium studyPatrick B Mark, Juan J Carrero, Kunihiro Matsushita, et al.
Nature Medicine|May 5, 2026
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individualsBrendon L Neuen, Rupert W Major, Morgan E Grams, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Journal of the American Society of Nephrology : JASN|March 1, 2023
The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 CohortsMorgan E Grams, Nigel J Brunskill, Shoshana H Ballew, et al.
European Heart Journal|January 24, 2023
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium studyPatrick B Mark, Juan J Carrero, Kunihiro Matsushita, et al.
Nature Medicine|May 5, 2026
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individualsBrendon L Neuen, Rupert W Major, Morgan E Grams, et al.
Pageof 8